Description
Parabolin
Manufacturer – Alpha Pharma
Product form – 5 ampoules of 76.5mg/1.5ml
The active substance is Trenbolone hexahydrobenzylcarbonate
Parabolin is a steroid that has a delayed action. And also Parabolin has a powerful anabolic androgenic activity, 5 times higher than testosterone and weak androgenic activity, 3 times lower than the male hormone. When using it, there is no aggravation of the aromatization process.
The release of the drug is carried out by the pharmacological company Alpha Pharma, located in India. Trenbolone hexahydrobenzylcarbonate is used as the active substance. The form of release is injections of 1.5 ml of 76.5 mg.
Read also about Tren Cycle For Cutting
Effects and properties of Parabolin
– It significantly increases the mass of muscle fibers in combination with Nandrolone
– It helps to increase the level of power indicators
– It eliminates excess fat accumulation
– It has a positive effect on the production of growth hormone
– It has an antibacterial effect
– It stimulates sexual desire during the reception process
Rules for taking the drug
It is recommended to run a course of up to 6 weeks. At the same time, no more than 300 milligrams should be taken per week at a time. It is also necessary to introduce Gonadotropin in the interval from the second week of the cycle to the second week following its end. As a post-course therapy, it is recommended to use Clomiphene.
See also about Trenbolone Side Effects
Rules for combining with other drugs
Parabolin has a powerful anabolic effect, so its combination with other steroids is not recommended. As a rare exception, a combination with Testosterone is strictly possible for professionals.
Potential side effects
– Increased aggression
– The appearance of acneiform rash
– The occurrence of hypertonia
– Sleep disturbance
– Testicular atrophy
– Decreased erection and libido
Reviews of the drug
Athletes’ reviews of Parabolin are positive in terms of the amount of strength and the quality of the gained mass.
Reviews
There are no reviews yet.